Press release

Press release

January 12, 2017

Follicum patent approved in Japan

Follicum AB announced on 9 January that the Japanese Patent Office (“JPO”) issued approval for the company’s patent application regarding the stimulation of hair growth. Thanks to this approval from the JPO, Follicum has protection in Japan for the company’s peptides in general and for the stimulation of hair growth specifically. The patent number is […]

January 12, 2017

Follicum patent approved in Russia

Follicum AB announced on 4 January that the Russian Patent Office  (“ROSPATENT”) issued approval for the company’s patent application regarding the stimulation of hair growth. Thanks to this approval from ROSPATENT, Follicum has protection in Russia for the company’s peptides in general and for the stimulation of hair growth specifically. The patent number is 2604797 […]

November 25, 2016

Q3 2016 Interim Report published

The Interim Report for Q3 2016, covering the period from   1 January 2016 to 30 September 2016, has now been published in Swedish. Read the full report here (in Swedish only)

November 23, 2016

Follicum’s clinical phase I/IIa study to be completed in January 2017

The multiple dose part of Follicum’s clinical phase I / II a study on candidate drug FOL-005, being conducted at the Charité University Hospital in Berlin, is expected to complete in January 2017 rather than before Christmas 2016, as previously announced. This multiple dose part of the study, in which two groups are treated with […]

August 26, 2016

2016 Half-year Report published

Follicum has today published the Half-year  Report for the period  1 January to  30 June, 2016. The report is available in Swedish only. Open the full report For more information please contact: Jan Alenfall, CEO Phone: +46 (0)46 19 21 97 Email: info@follicum.com  

June 20, 2016

Follicum AB receives patent is approved in the USA

Follicum announce that the patent application entitled “Novel Compositions and Uses Thereof”, covering the drug candidate FOL-005 and related compounds, has now been formally approved by the US Patent and Trademark Office (“USPTO”). Granting of this patent, number US 9,381,149, follows the “Intention to Grant” communicated on 11 March 2016. The administrative process at the USPTO regarding […]

June 13, 2016

Summary of the Annual General Meeting

On 13 June 2016 the Annual General Meeting was held in Follicum AB. The report is only available in Swedish. For more information, please contact: Jan Alenfall, CEO Tel: +46 (0)46 19 21 97 Email: info@follicum.com

May 30, 2016

Q1 2016 Interim Report published

First quarter  (2016-01-01  –  2016-03-31) Other operating income amounted to SEK 0  (SEK 0). Profit after financial items amounted to -5,270 TSEK (-5,609 TSEK). Earnings per share amounted to approximately -0.53 SEK (-0.63 SEK). The equity ratio amounted to approximately 82.3% (89.9%). See full Interim Report Q1 2016 (in Swedish) Definitions Earnings per share: Net […]

May 25, 2016

Last day of trading in FOLLI BTA

Last day of trading in the company´s paid subscribed share, FOLLI BTA is May 30, 2016. Information about the paid subscribed share: Shortname: FOLLI BTA ISIN-code: SE0008242895 Orderbook-ID: 121123 Last day of trading: May 30, 2016 Information in Swedish For more information, please contact AktieTorget phone +46 (0)8 511 68 000 or by e-mail info@aktietorget.se […]